Cutting-Edge Strategies in Massive Transfusion in Patients of Obstetric Hemorrhage
- *Corresponding Author:
- Ritcha Saxena
Department of Pathology
All Saints University School of Medicine
Email: [email protected]
Received date: November 15, 2016; Accepted date: December 09, 2016; Published date: December 16, 2016
Citation: Saxena R, Saxena A, Raj R, Marcelle T (2016) Cutting-Edge Strategies in Massive Transfusion in Patients of Obstetric Hemorrhage. J Gen Pract (Los Angel) 4:280. doi:10.4172/2329-9126.1000280
Copyright: © 2016 Saxena R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Obstetric hemorrhage is a life-threatening complication which may occur without warning, predictive signs and symptoms, and even in absence of predisposing conditions. It is a major cause of maternal mortality and morbidity almost invariably among all human races. One of the most important strategies in the control of obstetric hemorrhage is hemostatic resuscitation. The speed with which obstetric hemorrhage occurs makes it lifethreatening, but thankfully, it can be successfully managed with blood transfusion protocol based management. Resuscitation of massive hemorrhage has shifted towards the earlier administration of higher doses of fresh frozen plasma (FFP) and reducing serious complications and mortality by limiting the conventional use of crystalloids and colloids. In this article, we explored the leading-edge strategy of use of fibrinogen concentrates, cryoprecipitates, Tranexamic acid and prothrombin complex concentrates, apart from fresh frozen plasma as a promising alternative for obstetric resuscitation and for minimizing the risks and complications of obstetric hemorrhage.